U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SERELAXIN
W0122B976Y
Possibly Marketed Outside US
General
Record Details
Names
10
Classification
5
Identifiers
11
Subunits
2
Disulfide Links
3
Active Moiety
1
Characteristic Attributes
2
SERELAXIN
W0122B976Y
Possibly Marketed Outside US
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Sub Type
Sequence Type
COMPLETE
Record UNII
W0122B976Y
Record Status
Validated (UNII)
Record Version
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SERELAXIN
Official Name
English
RLX-030
Code
English
serelaxin [INN]
Common Name
English
RECOMBINANT HUMAN RELAXIN
Common Name
English
HUMAN RELAXIN RECOMBINANT
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
5
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Other vasodilators used in cardiac diseases
ATC
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
VASODILATORS USED IN CARDIAC DISEASES
Other vasodilators used in cardiac diseases
serelaxin
WHO-ATC
C01DX21
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of progressive systemic sclerosis.
FDA ORPHAN DRUG
92995
Agent Affecting Cardiovascular System
Pharmacologic Substance
[C1909]
Agent Affecting Cardiovascular System
[C78274]
Vasodilating Agent
NCI_THESAURUS
C29707
Other vasodilators used in cardiac diseases
VATC
CARDIAC THERAPY
VASODILATATORS USED IN CARDIAC DISEASE
Other vasodilators used in cardiac diseases
serelaxin
WHO-VATC
QC01DX21
HEART DISEASES
EMA EPAR
DISEASES
CARDIOVASCULAR DISEASES
HEART DISEASES
HEART FAILURE
EMA ASSESSMENT REPORTS
REASANZ (REFUSED: HEART FAILURE)
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C152342
PRIMARY
PUBCHEM
71300755
PRIMARY
EPA CompTox
DTXSID40244082
PRIMARY
DRUG BANK
DB05794
PRIMARY
WIKIPEDIA
Serelaxin
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
2
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Disulfide Links
3
Show
5
20
100
All
entries
From
To
From
To
1_11
2_11
1_23
2_24
2_10
2_15
Showing 1 to 3 of 3 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
W0122B976Y
SERELAXIN
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:SEQUENCE(CALCULATED)
CHEMICAL
SEQUENCE 5969 DA (average)
Molecular Formula
CHEMICAL
ESTIMATED
C256H415N74O75S8
Showing 1 to 2 of 2 entries
Previous
1
Next
